Chimeric Therapeutics Ltd. (AU:CHM) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Chimeric Therapeutics Ltd. has announced the issuance of 55 million unquoted equity securities, set to expire on various dates, indicating an active move in the capital markets. This development could influence the company’s stock activity on the ASX, drawing attention from investors focused on biotech innovations.
For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.